ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

METRNL mitigates oxidative stress and inflammatory drawbacks in ovalbumin/lipopolysaccharide-induced allergic airway diseases via the IKK/IκB/NF-κB signaling pathway.

Suzan A Khodir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.